MSA - MULTIPLE SYSTEM ATROPHY
Clinical trials for MSA - MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MSA - MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MSA - MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for managing dizzy spells in rare neurological disease
Symptom relief OngoingThis study is testing whether a drug called ampreloxetine can safely and effectively reduce symptoms of low blood pressure when standing in people with multiple system atrophy (MSA). About 102 participants will take the drug for 20 weeks, then some will be randomly switched to a …
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Scientists map the Brain's decline in 500 patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to better understand how various brain diseases progress over time. Researchers will follow about 500 adults with symptoms of conditions like Parkinson's disease or dementia for several years. Participants will have yearly check-ups that may include brain scans, m…
Matched conditions: MSA - MULTIPLE SYSTEM ATROPHY
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC